Detalhe da pesquisa
1.
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res
; 26(1): 20, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297352
2.
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
N Engl J Med
; 384(16): 1529-1541, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882206
3.
Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer.
Breast Cancer Res Treat
; 204(2): 289-297, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155272
4.
Addressing Residual Disease in HER2-Positive and Triple-Negative Breast Cancer: What Is Next?
Curr Oncol Rep
; 26(4): 336-345, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393609
5.
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
Curr Oncol Rep
; 26(1): 21-33, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198112
6.
Preoperative Risk Factors for Lymphedema in Inflammatory Breast Cancer.
J Reconstr Microsurg
; 40(4): 311-317, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751880
7.
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
Oncologist
; 28(7): 565-574, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210568
8.
Clinical Use of PARP Inhibitors in BRCA Mutant and Non-BRCA Mutant Breast Cancer.
Cancer Treat Res
; 186: 91-102, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978132
9.
Tailoring Treatment for Patients with Inflammatory Breast Cancer.
Curr Treat Options Oncol
; 24(6): 580-593, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043118
10.
Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.
Cancer
; 128(23): 4085-4094, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210737
11.
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane.
Breast Cancer Res Treat
; 196(3): 571-581, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280642
12.
Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study.
Breast Cancer Res Treat
; 192(2): 385-399, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997364
13.
Molecular characterization of ESR1 variants in breast cancer.
Breast Cancer Res Treat
; 196(2): 279-289, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125660
14.
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
Cancer
; 127(19): 3622-3630, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157782
15.
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function.
Breast Cancer Res Treat
; 185(3): 863-868, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400034
16.
Role of Platinums in Triple-Negative Breast Cancer.
Curr Oncol Rep
; 23(5): 50, 2021 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33754211
17.
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.
J Genet Couns
; 30(2): 383-393, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010199
18.
Management of Cardiovascular Disease in Women With Breast Cancer.
Circulation
; 139(8): 1110-1120, 2019 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779651
19.
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Breast Cancer Res Treat
; 184(2): 265-275, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776290
20.
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials.
Breast Cancer Res Treat
; 168(1): 35-41, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29119354